Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study

BACKGROUND: Endometrial cancer (EC) risk in BReast CAncer gene 1/2 (BRCA1/2) mutation carriers is uncertain; therefore, we assessed this in a large Dutch nationwide cohort study. METHODS: We selected 5980 BRCA1/2 (3788 BRCA1, 2151 gBRCA2, 41 both BRCA1/BRCA2) and 8451 non-BRCA1/2 mutation carriers f...

Descripción completa

Detalles Bibliográficos
Autores principales: de Jonge, Marthe M, de Kroon, Cornelis D, Jenner, Denise J, Oosting, Jan, de Hullu, Joanne A, Mourits, Marian J E, Gómez Garcia, Encarna B, Ausems, Margreet G E M, Margriet Collée, J, van Engelen, Klaartje, van de Beek, Irma, Smit, Vincent T H B M, Rookus, Matti A, de Bock, Geertruida H, van Leeuwen, Flora E, Bosse, Tjalling, Dekkers, Olaf M, van Asperen, Christi J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418438/
https://www.ncbi.nlm.nih.gov/pubmed/33710348
http://dx.doi.org/10.1093/jnci/djab036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418438/
https://www.ncbi.nlm.nih.gov/pubmed/33710348
http://dx.doi.org/10.1093/jnci/djab036

Ejemplares similares